Medifast, Inc.

Symbol: MED

NYSE

25.72

USD

Market price today

  • 4.1407

    P/E Ratio

  • -0.1029

    PEG Ratio

  • 281.30M

    MRK Cap

  • 0.13%

    DIV Yield

Medifast, Inc. (MED) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.73%

Operating Profit Margin

0.09%

Net Profit Margin

0.08%

Return on Assets

0.22%

Return on Equity

0.34%

Return on Capital Employed

0.36%

Company general description and statistics

Sector: Consumer Cyclical
Industry: Personal Products & Services
CEO:Mr. Daniel R. Chard
Full-time employees:634
City:Baltimore
Address:100 International Drive
IPO:1993-12-30
CIK:0000910329

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.

General Outlook

When we look at how much money they make before expenses, they keep 0.732% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.090%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.075%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.224% return, is a testament to Medifast, Inc.'s adeptness in optimizing resource deployment. Medifast, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.343%. Furthermore, the proficiency of Medifast, Inc. in capital utilization is underscored by a remarkable 0.358% return on capital employed.

Stock Prices

Medifast, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $27.41, while its low point bottomed out at $25.92. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Medifast, Inc.'s stock market.

Liquidity Ratios

Analyzing MED liquidity ratios reveals its financial health of the firm. The current ratio of 284.48% gauges short-term asset coverage for liabilities. The quick ratio (202.66%) assesses immediate liquidity, while the cash ratio (126.28%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio284.48%
Quick Ratio202.66%
Cash Ratio126.28%

Profitability Ratios

MED profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 9.70% underscores its earnings before tax deductions. The effective tax rate stands at 22.16%, revealing its tax efficiency. The net income per EBT, 77.84%, and the EBT per EBIT, 107.70%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 9.00%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin9.70%
Effective Tax Rate22.16%
Net Income per EBT77.84%
EBT per EBIT107.70%
EBIT per Revenue9.00%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 2.84, it details the span from stock purchase to revenue. The 2 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 89781100000.00% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding203
Days of Inventory Outstanding70
Operating Cycle70.06
Days of Payables Outstanding108
Cash Conversion Cycle-38
Receivables Turnover897811000.00
Payables Turnover3.38
Inventory Turnover5.21
Fixed Asset Turnover13.70
Asset Turnover2.97

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 8.33, and free cash flow per share, 7.76, depict cash generation on a per-share basis. The cash per share value, 14.34, showcases liquidity position. A payout ratio of 0.81 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.10, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share8.33
Free Cash Flow per Share7.76
Cash per Share14.34
Payout Ratio0.81
Operating Cash Flow Sales Ratio0.10
Free Cash Flow to Operating Cash Flow Ratio0.93
Cash Flow Coverage Ratio4.42
Short Term Coverage Ratio15.25
Capital Expenditure Coverage Ratio14.64
Dividend Paid and Capex Coverage Ratio1.50
Dividend Payout Ratio0.10

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 6.79%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.10, we discern the balance between debt and equity financing. The long-term debt to capitalization, 6.48%, and total debt to capitalization, 8.88%, ratios shed light on its capital structure. An interest coverage of 29.74 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio6.79%
Debt Equity Ratio0.10
Long Term Debt to Capitalization6.48%
Total Debt to Capitalization8.88%
Interest Coverage29.74
Cash Flow to Debt Ratio4.42
Company Equity Multiplier1.44

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 98.50, provides a glimpse into top-line earnings distributed across each share. Net income per share, 9.13, reflects the portion of profit attributed to each share. The book value per share, 18.51, represents the net asset value distributed per share, while the tangible book value per share, 18.51, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share98.50
Net Income Per Share9.13
Book Value Per Share18.51
Tangible Book Value Per Share18.51
Shareholders Equity Per Share18.51
Interest Debt Per Share2.02
Capex Per Share-0.60

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -32.94%, indicates top-line expansion, while the gross profit growth, -31.97%, reveals profitability trends. EBIT growth, -31.60%, and operating income growth, -31.60%, offer insights into operational profitability progression. The net income growth, -30.75%, showcases bottom-line expansion, and the EPS growth, -28.78%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-32.94%
Gross Profit Growth-31.97%
EBIT Growth-31.60%
Operating Income Growth-31.60%
Net Income Growth-30.75%
EPS Growth-28.78%
EPS Diluted Growth-28.52%
Weighted Average Shares Growth-2.78%
Weighted Average Shares Diluted Growth-3.15%
Dividends per Share Growth4.86%
Operating Cash Flow Growth-24.11%
Free Cash Flow Growth-20.64%
10-Year Revenue Growth per Share280.16%
5-Year Revenue Growth per Share134.88%
3-Year Revenue Growth per Share24.02%
10-Year Operating CF Growth per Share341.14%
5-Year Operating CF Growth per Share166.51%
3-Year Operating CF Growth per Share9.98%
10-Year Net Income Growth per Share424.90%
5-Year Net Income Growth per Share95.60%
3-Year Net Income Growth per Share4.53%
10-Year Shareholders Equity Growth per Share159.09%
5-Year Shareholders Equity Growth per Share102.70%
3-Year Shareholders Equity Growth per Share38.57%
5-Year Dividend per Share Growth per Share246.06%
3-Year Dividend per Share Growth per Share48.46%
Receivables Growth872699900.00%
Inventory Growth-54.07%
Asset Growth-1.99%
Book Value per Share Growth33.66%
Debt Growth-15.50%
R&D Expense Growth2.22%
SGA Expenses Growth-32.04%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 659,194,480, captures the company's total value, considering both debt and equity. Income quality, 1.49, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.60, gauges operational efficiency, while the research and development to revenue, 0.43%, highlights investment in innovation.

cards.indicatorcards.value
Enterprise Value659,194,480
Income Quality1.49
Sales General and Administrative to Revenue0.60
Research and Development to Revenue0.43%
Capex to Operating Cash Flow-4.39%
Capex to Revenue-0.60%
Capex to Depreciation-49.46%
Stock-Based Compensation to Revenue0.76%
Graham Number61.68
Return on Tangible Assets32.08%
Graham Net Net6.93
Working Capital131,729,000
Tangible Asset Value201,481,000
Net Current Asset Value115,602,000
Average Receivables4,363,500.5
Average Payables48,930,000
Average Inventory86,723,500
Days Sales Outstanding3
Days Payables Outstanding48
Days of Inventory On Hand67
ROIC43.66%
ROE0.49%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.33, and the price to book ratio, 1.33, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.31, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 3.32, and price to operating cash flows, 3.09, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio1.33
Price to Book Ratio1.33
Price to Sales Ratio0.31
Price Cash Flow Ratio3.09
Price Earnings to Growth Ratio-0.10
Enterprise Value Multiple3.76
Price Fair Value1.33
Price to Operating Cash Flow Ratio3.09
Price to Free Cash Flows Ratio3.32
Price to Tangible Book Ratio3.63
Enterprise Value to Sales0.61
Enterprise Value Over EBITDA4.73
EV to Operating Cash Flow4.46
Earnings Yield13.59%
Free Cash Flow Yield19.30%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Medifast, Inc. (MED) on the NYSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 4.141 in 2024.

What is the ticker symbol of Medifast, Inc. stock?

The ticker symbol of Medifast, Inc. stock is MED.

What is company IPO date?

IPO date of Medifast, Inc. is 1993-12-30.

What is company current share price?

Current share price is 25.720 USD.

What is stock market cap today?

The market cap of stock today is 281304784.000.

What is PEG ratio in 2024?

The current -0.103 is -0.103 in 2024.

What is the number of employees in 2024?

In 2024 the company has 634.